{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:01:04Z","timestamp":1781107264646,"version":"3.54.1"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Mass administration of azithromycin reduced child mortality in parts of sub-Saharan Africa. Promotion of infant growth may be an additional benefit of azithromycin treatment.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To investigate whether the provision of mass administration of azithromycin for infants aged 1 to 11 months improves growth outcomes.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cluster randomized clinical trial conducted from December 1, 2020, to December 31, 2024, included 1151 villages in southwestern Mali. Villages were randomized in a 3:4:2 ratio to placebo, twice-yearly azithromycin, or quarterly azithromycin. Participants and study personnel were masked. The prespecified growth substudy, conducted from August 31, 2022, to July 31, 2023, was conducted in 59 villages in the Kita region. Eligible participants were infants aged 1 to 11 months, weighing 3.0 kg or more, with no macrolide allergy or severe illness. Anthropometric data were collected cross-sectionally from children aged 6 to 8 months and 12 to 14 months at 15, 18, 21, and 24 months after village enrollment.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Infants received a single oral dose of azithromycin, 20 mg\/kg, at each quarterly visit: placebo at all rounds (control); azithromycin at 2 rounds from January to June and placebo at 2 rounds from July to December (twice-yearly azithromycin); or azithromycin at all rounds (quarterly azithromycin).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n Prespecified outcomes were weight and length; weight-for-age (WA), length-for-age (LA), weight-for-length (WL), and mid-upper-arm circumference (MUAC)\n z<\/jats:italic>\n scores; and underweight, stunting, and wasting. Analysis was performed on an intention-to-treat basis.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 1205 infants (mean age, 5.7 months [95% CI, 5.6-5.9 months]; 633 boys [52.5%]) were included in the trial at baseline. Among 1789 children (923 boys [51.6%]) assessed for growth, the mean anthropometric indices did not differ between the placebo, twice-yearly azithromycin, and quarterly azithromycin groups: weight, 7.8 kg (95% CI, 7.7-7.9 kg), 7.8 kg (95% CI, 7.7-7.9 kg), and 7.8 kg (95% CI, 7.7-7.9 kg), respectively; length, 70.2 cm (95% CI, 69.9-70.8 cm), 70.6 cm (95% CI, 70.2-70.9 cm), and 70.6 cm (95% CI, 70.1-71.0 cm), respectively; WA\n z<\/jats:italic>\n score, \u20131.12 (95% CI, \u22121.23 to \u22120.95), \u22121.10 (95% CI, \u22121.19 to \u22120.98), and \u22121.12 (95% CI, \u22121.27 to \u22121.01), respectively; LA\n z<\/jats:italic>\n score, \u22120.86 (95% CI, \u22121.06 to \u22120.70), \u20130.79 (95% CI, \u22120.93 to \u22120.65), and \u20130.78 (95% CI, \u22120.98 to \u22120.63), respectively; WL\n z<\/jats:italic>\n score, \u20130.87 (95% CI, \u22121.00 to \u22120.68), \u22120.89 (95% CI, \u22121.01 to \u22120.77), and \u22120.95 (95% CI, \u22121.12 to \u22120.81), respectively; and MUAC\n z<\/jats:italic>\n score, \u22120.30 (95% CI, \u22120.43 to \u22120.10), \u22120.24 (95% CI, \u22120.37 to \u22120.12), and \u22120.26 (95% CI, \u22120.41 to \u22120.10), respectively. The proportions of underweight, stunting, and wasting did not differ between groups.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this prespecified analysis of secondary outcomes of a cluster randomized clinical trial of the provision of mass administration of azithromycin for infants aged 1 to 11 months, growth outcomes did not differ between azithromycin and placebo groups. These findings suggest that mass administration of azithromycin to infants is unlikely to promote growth.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT04424511<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.17425","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:30:34Z","timestamp":1781105434000},"page":"e2617425","source":"Crossref","is-referenced-by-count":0,"title":["Infant Growth After Mass Administration of Azithromycin"],"prefix":"10.1001","volume":"9","author":[{"given":"Laura","family":"Adubra","sequence":"first","affiliation":[{"name":"Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juho","family":"Luoma","sequence":"additional","affiliation":[{"name":"Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Mei","family":"Fan","sequence":"additional","affiliation":[{"name":"Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadima Cheick","family":"Haidara","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development\u2013Mali, Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumar","family":"Samak\u00e9","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development\u2013Mali, Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikhard","family":"Ihamuotila","sequence":"additional","affiliation":[{"name":"Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Ylikruuvi","sequence":"additional","affiliation":[{"name":"Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Hallamaa","sequence":"additional","affiliation":[{"name":"Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Martell","sequence":"additional","affiliation":[{"name":"Tro Da Ltd, Caerphilly, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Ducker","sequence":"additional","affiliation":[{"name":"Tro Da Ltd, Caerphilly, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Alber","sequence":"additional","affiliation":[{"name":"Great Ormond Street Institute of Child Health, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ashorn","sequence":"additional","affiliation":[{"name":"Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Bun","family":"Cheung","sequence":"additional","affiliation":[{"name":"Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samba","family":"Sow","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development\u2013Mali, Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Ashorn","sequence":"additional","affiliation":[{"name":"Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"9","key":"zoi260488r1","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2009.1266","article-title":"Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.","volume":"302","author":"Porco","year":"2009","journal-title":"JAMA"},{"issue":"7","key":"zoi260488r2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/cid\/cir069","article-title":"Childhood mortality in a cohort treated with mass azithromycin for trachoma.","volume":"52","author":"Keenan","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"zoi260488r3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/INF.0000000000001992","article-title":"Childhood mortality after mass distribution of azithromycin: a secondary analysis of the PRET Cluster-randomized trial in Niger.","volume":"37","author":"O\u2019Brien","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"17","key":"zoi260488r4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1715474","article-title":"Azithromycin to reduce childhood mortality in sub-Saharan Africa.","volume":"378","author":"Keenan","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi260488r5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa2312093","article-title":"Azithromycin to reduce mortality\u2014an adaptive cluster-randomized trial.","volume":"391","author":"O\u2019Brien","year":"2024","journal-title":"N Engl J Med"},{"key":"zoi260488r6","doi-asserted-by":"publisher","first-page":"g2267","DOI":"10.1136\/bmj.g2267","article-title":"The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials.","volume":"348","author":"Gough","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"zoi260488r7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/MPG.0000000000001640","article-title":"Early antibiotic exposure in low-resource settings is associated with increased weight in the first two years of life.","volume":"65","author":"Rogawski","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"zoi260488r8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1542\/peds.2014-3407","article-title":"Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life.","volume":"135","author":"Saari","year":"2015","journal-title":"Pediatrics"},{"key":"zoi260488r10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-017227","article-title":"Infants less than 6 months of age at risk of poor growth and development: evidence gaps identified during WHO guideline development.","volume":"10","author":"Kerac","year":"2025","journal-title":"BMJ Glob Health"},{"key":"zoi260488r11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003128","author":"Amza","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"zoi260488r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.39351","article-title":"Effect of mass azithromycin distributions on childhood growth in Niger: a cluster-randomized trial.","volume":"4","author":"Arzika","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi260488r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007442","article-title":"Linear growth in preschool children treated with mass azithromycin distributions for trachoma: a cluster-randomized trial.","volume":"13","author":"Keenan","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"zoi260488r14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004345","article-title":"Single-dose azithromycin for infant growth in Burkina Faso: prespecified secondary anthropometric outcomes from a randomized controlled trial.","volume":"21","author":"Si\u00e9","year":"2024","journal-title":"PLoS Med"},{"issue":"5","key":"zoi260488r15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.4269\/ajtmh.22-0763","article-title":"Neonatal azithromycin administration and growth during infancy: a randomized controlled trial.","volume":"108","author":"Sie","year":"2023","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"zoi260488r16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0001009","article-title":"Infant mortality and growth failure after oral azithromycin among low birthweight and underweight neonates: a subgroup analysis of a randomized controlled trial.","volume":"3","author":"Bountogo","year":"2023","journal-title":"PLOS Glob Public Health"},{"key":"zoi260488r17","doi-asserted-by":"publisher","author":"Bountogo","journal-title":"Am J Trop Med Hyg","DOI":"10.4269\/ajtmh.24-0016"},{"issue":"8","key":"zoi260488r18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0328208","article-title":"Azithromycin for infants at risk of poor growth and development: a pooled secondary analysis of two randomized controlled trials.","volume":"20","author":"Bountogo","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"zoi260488r19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13063-022-06966-7","article-title":"Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial.","volume":"24","author":"Adubra","year":"2023","journal-title":"Trials"},{"issue":"15","key":"zoi260488r20","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1056\/NEJMoa2504644","article-title":"Mass administration of azithromycin to infants in Mali to reduce mortality.","volume":"393","author":"Haidara","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi260488r21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/s13063-023-07771-6","article-title":"Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali.","volume":"24","author":"Luoma","year":"2023","journal-title":"Trials"},{"issue":"S450","key":"zoi260488r25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1651-2227.2006.tb02378.x","article-title":"WHO Child Growth Standards based on length\/height, weight and age.","volume":"450","author":"de Onis","year":"2006","journal-title":"Acta Paediatr Suppl"},{"issue":"3","key":"zoi260488r26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2307\/2533558","article-title":"Small sample inference for fixed effects from restricted maximum likelihood.","volume":"53","author":"Kenward","year":"1997","journal-title":"Biometrics"},{"issue":"7","key":"zoi260488r27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.19693","article-title":"Spillover of azithromycin mass drug administration and child survival: a secondary analysis of a cluster-randomized clinical trial.","volume":"8","author":"Arzika","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi260488r28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000471876","article-title":"The physiology of childhood growth: hormonal regulation.","volume":"88","author":"Benyi","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"zoi260488r29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1651-2227.1990.tb11645.x","article-title":"The infancy-childhood growth spurt.","volume":"367","author":"Karlberg","year":"1990","journal-title":"Acta Paediatr Scand Suppl"},{"issue":"2","key":"zoi260488r30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ajmg.c.31357","article-title":"Endocrine control of growth.","volume":"163C","author":"Murray","year":"2013","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"zoi260488r31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000071219","article-title":"Growth hormone deficiency (GHD) from birth to 2 years of age: diagnostic specifics of GHD during the early phase of life.","volume":"60","author":"Ogilvy-Stuart","year":"2003","journal-title":"Horm Res"},{"issue":"9","key":"zoi260488r32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003617","article-title":"Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: a factorial randomized, double-blind, placebo-controlled trial.","volume":"18","author":"DeBoer","year":"2021","journal-title":"PLoS Med"},{"issue":"1","key":"zoi260488r33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s41043-025-00808-3","article-title":"Precipitation, temperature, and child undernutrition: evidence from the Mali Demographic and Health Surveys 2012-2013 and 2018.","volume":"44","author":"Kamiya","year":"2025","journal-title":"J Health Popul Nutr"},{"key":"zoi260488r34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.apgeog.2011.08.009","article-title":"Climate change and human health: spatial modeling of water availability, malnutrition, and livelihoods in Mali, Africa.","volume":"33","author":"Jankowska","year":"2012","journal-title":"Appl Geogr"},{"key":"zoi260488r9","volume-title":"WHO Guideline on the Prevention and Management of Wasting and Nutritional Oedema (Acute Malnutrition) in Infants and Children Under 5 Years","author":"World Health Organization","year":"2023"},{"key":"zoi260488r22","unstructured":"Ashorn P, Ashorn U, Cheung YB, Ducker C, Klein N, Sow SO. LAKANA trial: a research plan for a cluster-randomized, double-blinded, parallel group, controlled trial, testing the effects of mass-drug administration of azithromycin on mortality and other outcomes among 1\u201311-month-old infants in rural Mali. Accessed October 6, 2025. https:\/\/lakana.org\/wp-content\/uploads\/LAKANA-protocol-version-7.0-2024-11-13_clean.pdf"},{"key":"zoi260488r23","unstructured":"WHO guideline on mass drug administration of azithromycin to children under five years of age to promote child survival. World Health Organization. 2020. Accessed March 24, 2022. https:\/\/apps.who.int\/iris\/handle\/10665\/333942"},{"key":"zoi260488r24","doi-asserted-by":"crossref","unstructured":"Haidara? FC, Adubra? L, Abdou? M, . Mass administration of azithromycin to infants does not promote their survival in Mali. VeriXiv. Preprint posted online April 23, 2025. doi:10.12688\/verixiv.978.1","DOI":"10.12688\/verixiv.978.1"},{"key":"zoi260488r35","unstructured":"Rapport final Enqu\u00eate SMART-Rapide (mai-juin 2024)\u2014Des cercles et des sites PDI en phase 4 des r\u00e9gions de Mopti, Tombouctou, Gao, Kidal, M\u00e9naka, Bandiagara, et Douentza\u2014juin 2024. Minist\u00e8re de la sant\u00e9 et du d\u00e9veloppement sociale, UNICEF, ACF, IRC, World Vision WVI. August 6, 2024. Accessed September 16, 2025. https:\/\/reliefweb.int\/node\/4084053"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2850137\/adubra_2026_oi_260488_1780432341.25236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:30:38Z","timestamp":1781105438000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2850137"}},"subtitle":["Secondary Outcomes of a Cluster Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.17425","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}